Log in
Login
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nasdaq  >  Alnylam Pharmaceuticals, Inc.    ALNY

Delayed Quote. Delayed  - 04/29 09:59:59 pm
67.04 USD   -1.24%
04/28 ALNYLAM PHARMAC : to Break Ground on New Manufacturing Facility in N..
04/26 ALNYLAM PHARMAC : to Webcast Presentations at Upcoming May Investor ..
04/25 ALNYLAM PHARMAC : to Webcast Conference Call Discussing First Quarte..
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
04/25/2016 04/26/2016 04/27/2016 04/28/2016 04/29/2016 Date
71.95(c) 70.37(c) 68.63(c) 67.88(c) 67.04(c) Last
433 145 592 380 446 854 474 202 424 483 Volume
+0.13% -2.20% -2.47% -1.09% -1.24% Change
More quotes
Financials ($)
Sales 2016 40,0 M
EBIT 2016 -379 M
Net income 2016 -363 M
Finance 2016 246 M
Yield 2016 -
Sales 2017 56,6 M
EBIT 2017 -417 M
Net income 2017 -426 M
Finance 2017 330 M
Yield 2017 -
P/E ratio 2016 -
P/E ratio 2017
EV / Sales 2016 137x
EV / Sales 2017 95,3x
Capitalization 5 722 M
More Financials
Company
Alnylam Pharmaceuticals, Inc. is a biopharmaceutical company, which discovery, development and commercialization of RNAi therapeutics.It is the translation of RNAi as a new class of innovative medicines with a core focus on RNAi therapeutics for the treatment of genetically defined diseases.The... 
More about the company
Surperformance© ratings of Alnylam Pharmaceuticals, I
Trading Rating : Investor Rating :
More Ratings
Latest news on ALNYLAM PHARMACEUTICALS, I
04/28 ALNYLAM PHARMACEUTICALS : Reports Complete 18-Month Data from Ongoing Phase 2 Op..
04/28 ALNYLAM PHARMACEUTICALS : to Break Ground on New Manufacturing Facility in Norto..
04/26 ALNYLAM PHARMACEUTICALS : to Webcast Presentations at Upcoming May Investor Conf..
04/25 ALNYLAM PHARMACEUTICALS : to Webcast Conference Call Discussing First Quarter 20..
04/20 ALNYLAM PHARMACEUTICALS : Reports Complete 18-Month Data from Ongoing Phase 2 Op..
04/08 ALNYLAM PHARMACEUTICALS : Other Events (form 8-K)
04/06 ALNYLAM PHARMACEUTICALS : to Webcast Presentation at 15th Annual Needham Healthc..
03/24 ALNYLAM PHARMACEUTICALS : Initiates Fitusiran ALN-AT3 Dosing in Hemophilia A and..
More news
Sector news : Biotechnology & Medical Research - NEC
04/29 SANOFI : offers to buy Medivation for $9.3bn
04/29 SANOFI : France's Sanofi makes $9.3 billion bid for US cancer drug giant
04/29DJSanofi Seeks Talks With Medivation Over $9.3 Billion Offer -- 2nd Update
More sector news : Biotechnology & Medical Research - NEC
News from SeekingAlpha
04/20 Alnylam's patisiran shows treatment benefit in mid-stage study in rare inheri..
04/08 PCSK9 Drugs Are Overhyped - Why Amgen's FOURIER CVOT Will Disappoint
04/01 BIOTECH FORUM DAILY DIGEST : Medivation Roller-Coaster, Spotlight On Regulus The..
03/28 Smart-Money Healthcare Investing Focuses On Major Biotech Stocks
03/24 WELL-FED ANALYSTS AND THE NEVER-ENDI : Why You Should Short Alnylam


Comments 
Advertisement
Chart ALNYLAM PHARMACEUTICALS, I
Duration : Period :
Alnylam Pharmaceuticals, I Technical Analysis Chart | ALNY | US02043Q1076 | 4-Traders
Full-screen chart
Technical analysis trends ALNYLAM PHARMACEU...
Short TermMid-TermLong Term
TrendsBullishBearishBearish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions